SCHEMBL19202293

SCHEMBL19202293

Cc1ccc2c(C(=O)O)c(O)c(O)cc2c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 6/20 0.58
LDHB P07195 6/20 0.58
ALB P02768 1/20 0.54
DHODH Q02127 3/20 0.48
CSNK2A1 P68400 1/20 0.46
GLRA3 O75311 1/20 0.42
GLRB P48167 1/20 0.42
PIN1 Q13526 1/20 0.40
DAO P14920 1/20 0.40
MPL P40238 1/20 0.40
POLB P06746 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP1A2 P05177 1/20 0.39
GLA P06280 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19202406 0.86 LDHA (0.58) LDHALDHBALBDHODHCSNK2A1
SCHEMBL19202491 0.86 LDHA (0.54) LDHALDHBALBDHODHCSNK2A1
SCHEMBL24116339 0.82 CA12 (0.42) LDHALDHBALBDHODHGLRA3
SCHEMBL19203353 0.81 CSNK2A1 (0.52) LDHALDHBALBDHODHCSNK2A1
SCHEMBL11777447 0.79 GLRA3 (0.50) LDHALDHBALBDHODHGLRA3
SCHEMBL6355043 0.77 TRPA1 (0.44) LDHALDHBALBCSNK2A1DAO
SCHEMBL10111010 0.77 CYP1A2 (0.53) LDHALDHBALBDHODHCSNK2A1
SCHEMBL88986 0.77 CYP1A2 (0.68) LDHADHODHPOLBMEN1KMT2A
SCHEMBL29779946 0.77 CYP1A2 (0.68) LDHADHODHPOLBMEN1KMT2A
SCHEMBL931067 0.76 LDHA (0.50) LDHALDHBALBDHODHCSNK2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170217999-A1 SURFACE PRIMER COMPOSITIONS AND METHODS OF USE ORMCO CORPORATION 2017-08-03 US disclosed
WO-2017132463-A1 SURFACE PRIMER COMPOSITIONS AND METHODS OF USE ACatechol, Inc. (US) 2017-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170217999-A1 SURFACE PRIMER COMPOSITIONS AND METHODS OF USE SP1, GPER1, GRIN1 LDHA 2656/4885LDHB 2298/4885ALB 1999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.